EP4058025A4 - Pharmaceutical compositions comprising ticagrelor - Google Patents

Pharmaceutical compositions comprising ticagrelor Download PDF

Info

Publication number
EP4058025A4
EP4058025A4 EP19952515.5A EP19952515A EP4058025A4 EP 4058025 A4 EP4058025 A4 EP 4058025A4 EP 19952515 A EP19952515 A EP 19952515A EP 4058025 A4 EP4058025 A4 EP 4058025A4
Authority
EP
European Patent Office
Prior art keywords
ticagrelor
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19952515.5A
Other languages
German (de)
French (fr)
Other versions
EP4058025A1 (en
Inventor
Ersin Yildirim
Bayram Kanik
Fatma ÖZTÜRK
Tansel AKTA
Filiz ÖZYÜREK
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santa Farma Ilac Sanayi AS
Original Assignee
Santa Farma Ilac Sanayi AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santa Farma Ilac Sanayi AS filed Critical Santa Farma Ilac Sanayi AS
Publication of EP4058025A1 publication Critical patent/EP4058025A1/en
Publication of EP4058025A4 publication Critical patent/EP4058025A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
EP19952515.5A 2019-11-13 2019-11-13 Pharmaceutical compositions comprising ticagrelor Pending EP4058025A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/TR2019/050944 WO2021096444A1 (en) 2019-11-13 2019-11-13 Pharmaceutical compositions comprising ticagrelor

Publications (2)

Publication Number Publication Date
EP4058025A1 EP4058025A1 (en) 2022-09-21
EP4058025A4 true EP4058025A4 (en) 2023-08-02

Family

ID=75913166

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19952515.5A Pending EP4058025A4 (en) 2019-11-13 2019-11-13 Pharmaceutical compositions comprising ticagrelor

Country Status (2)

Country Link
EP (1) EP4058025A4 (en)
WO (1) WO2021096444A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023222660A1 (en) * 2022-05-16 2023-11-23 Hyloris Developments Sa Aqueous ticagrelor solutions, method of manufacturing and uses
WO2023222184A1 (en) * 2022-05-16 2023-11-23 Hyloris Developments Sa Aqueous ticagrelor solution, method of manufacturing and uses

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170296666A1 (en) * 2016-04-18 2017-10-19 Amneal Pharmaceuticals Company Gmbh Stable Pharmaceutical Composition Of Amorphous Ticagrelor
EP3332769A1 (en) * 2016-12-07 2018-06-13 Sanovel Ilac Sanayi ve Ticaret A.S. Solid oral pharmaceutical compositions of ticagrelor
WO2018229785A1 (en) * 2017-06-15 2018-12-20 Natco Pharma Limited Pharmaceutical compositions of ticagrelor
WO2021080529A1 (en) * 2019-10-26 2021-04-29 Santa Farma İlaç Sanayi̇ A.Ş. Solid pharmaceutical formulations comprising ticagrelor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201129386A (en) * 2009-11-05 2011-09-01 Fmc Corp Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
TR201601835A2 (en) * 2016-02-12 2017-08-21 Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi PRODUCTION METHOD FOR FORMULATIONS CONTAINING TIKAGRELOR

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170296666A1 (en) * 2016-04-18 2017-10-19 Amneal Pharmaceuticals Company Gmbh Stable Pharmaceutical Composition Of Amorphous Ticagrelor
EP3332769A1 (en) * 2016-12-07 2018-06-13 Sanovel Ilac Sanayi ve Ticaret A.S. Solid oral pharmaceutical compositions of ticagrelor
WO2018229785A1 (en) * 2017-06-15 2018-12-20 Natco Pharma Limited Pharmaceutical compositions of ticagrelor
WO2021080529A1 (en) * 2019-10-26 2021-04-29 Santa Farma İlaç Sanayi̇ A.Ş. Solid pharmaceutical formulations comprising ticagrelor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2021096444A1 *

Also Published As

Publication number Publication date
WO2021096444A1 (en) 2021-05-20
EP4058025A1 (en) 2022-09-21

Similar Documents

Publication Publication Date Title
EP3817722A4 (en) Pharmaceutical compositions comprising meloxicam
EP4045480A4 (en) Pharmaceutical formulations
EP3641771A4 (en) Pharmaceutical compositions
AU2018302170A1 (en) Pharmaceutical compositions comprising entrectinib
EP3946316A4 (en) Cannabidiol pharmaceutical compositions
GB201911517D0 (en) Pharmaceutical composition
EP3781135A4 (en) Solid oral pharmaceutical compositions comprising sitagliptin
IL290894A (en) Pharmaceutical formulation
EP3868371A4 (en) Novel pharmaceutical composition
EP4058025A4 (en) Pharmaceutical compositions comprising ticagrelor
EP4135699A4 (en) Pharmaceutical compositions
EP4048276A4 (en) Solid pharmaceutical formulations comprising ticagrelor
EP3881841A4 (en) Pharmaceutical composition
EP3817744A4 (en) Ivosidenib forms and pharmaceutical compositions
EP3914234A4 (en) Pharmaceutical compositions
EP4005556A4 (en) Pharmaceutical composition comprising udenafil
EP3984549A4 (en) Medicinal composition
EP3950058A4 (en) Pharmaceutical composition having favorable stability
EP3949952A4 (en) Medicinal composition
EP3920909A4 (en) Pharmaceutical compositions comprising meloxicam
EP3964264A4 (en) Novel pharmaceutical composition
EP4081251A4 (en) Pharmaceutical compositions
EP3841108A4 (en) Pharmaceutical compositions comprising integration-promoting peptides
FI3908321T3 (en) Pharmaceutical composition
GB201906473D0 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220513

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20230629

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/20 20060101ALI20230623BHEP

Ipc: A61K 47/00 20060101ALI20230623BHEP

Ipc: A61K 9/28 20060101ALI20230623BHEP

Ipc: A61K 31/519 20060101AFI20230623BHEP